Is HELE a Buy? What to Consider in 2026
Short answer
The bull case for Helen of Troy Limited (HELE) rests on Leadership Brand portfolio: Helen of Troy concentrates investment behind a handful of scaled brands including OXO, Hydro Flask, Osprey, Vicks, Braun and Honeywell. Revenue (TTM) is ~$1.80 billion. If you believe that thesis holds, the real questions become position sizing and overlap, not timing. The main risk to that view: Revenue has been declining, and a rebound is not guaranteed given consumer discretionary softness and competitive private-label pressure. Whether HELE is a buy comes down to whether you believe the thesis. This is informational, not a recommendation, and Walnut is not an investment adviser.
Helen of Troy Limited designs, markets and distributes consumer products across two segments: Home & Outdoor (OXO kitchen and storage tools, Hydro Flask hydration bottles, Osprey packs, PUR filtration) and Beauty & Wellness (Braun and Vicks health devices, Honeywell air treatment, Hot Tools and Drybar hair appliances, Curlsmith). The company sells through mass retail, specialty, and online channels, and manages a portfolio it calls its Leadership Brands while periodically acquiring and divesting smaller labels. Trailing revenue is roughly $1.80 billion (as of June 2026), and the business generates meaningful free cash flow even as top-line sales have softened. The investment picture is that of a leveraged turnaround. HELE reported a large GAAP net loss (~$899 million) driven mainly by an ~$886 million non-cash goodwill and intangibles writedown, while adjusted profitability and free cash flow stayed positive and the company paid down debt toward ~$716 million (as of June 2026). With a market cap near $641 million against ~$1.80 billion of sales, the stock trades at a low price-to-sales multiple that reflects real concerns: declining sales at some Leadership Brands, tariff exposure on imported goods, and a debt load that constrains flexibility. Bulls focus on cash generation, cost restructuring (the Pegasus program) and cheap valuation; bears point to shrinking revenue and balance-sheet risk.
What's the case for buying HELE?
1. Leadership Brand portfolio
Helen of Troy concentrates investment behind a handful of scaled brands including OXO, Hydro Flask, Osprey, Vicks, Braun and Honeywell. Performance is uneven across the portfolio (Osprey has grown while Hydro Flask has slipped in recent quarters), so the near-term story is about stabilizing the softer brands while defending share in the stronger ones.
2. Cost restructuring and cash flow
The Pegasus and related restructuring programs aim to cut costs, simplify operations and lift margins. Even with declining sales, the company has produced solid free cash flow (over $100 million in a single recent quarter as of June 2026), which it has been directing toward debt reduction rather than buybacks or a dividend.
3. Debt paydown and balance sheet
With total debt around $716 million and a debt-to-equity ratio above 1.0 (as of June 2026), deleveraging is central to the thesis. Continued free cash flow that reduces borrowings would lower interest expense and financial risk, while any cash-flow shortfall would leave the balance sheet stretched.
4. Tariff and cost management
Much of Helen of Troy's product is sourced abroad, so tariffs and input costs directly pressure gross margin, which compressed to roughly 44.6% in the latest quarter (as of June 2026). Management guidance and pricing actions are aimed at absorbing these headwinds, and the market has reacted sharply to quarters that beat lowered expectations.
What are the risks to HELE?
Revenue has been declining, and a rebound is not guaranteed given consumer discretionary softness and competitive private-label pressure. The company carries meaningful debt (~$716 million as of June 2026), so a downturn in cash flow would raise refinancing and covenant risk. Tariffs and imported-goods costs weigh on margins, and the large recent goodwill writedown signals that past acquisitions were carried above their current worth. HELE pays no dividend, and the low market capitalization relative to sales reflects genuine uncertainty rather than a guaranteed value opportunity.
How is HELE valued? (as of JUNE 2026)
Snapshot for HELE as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
- Revenue (TTM): ~$1.80 billion
- Market cap: ~$641 million
- Q4 FY2026 net sales: ~$470 million
- Q4 FY2026 adjusted EPS: ~$0.83
- Total debt: ~$716 million
- FY2027 net sales guidance: ~$1.76 to $1.83 billion
HELE trades at a low price-to-sales multiple (market cap roughly a third of trailing revenue as of June 2026), which reflects declining sales and a leveraged balance sheet rather than a clear bargain. A large non-cash goodwill and intangibles writedown (~$886 million) drove a sizable GAAP net loss, while adjusted earnings and free cash flow remained positive. Valuation multiples on GAAP earnings are distorted by that charge, so cash flow and sales trends are the more useful gauges here.
How do you decide if HELE is a buy?
Rather than asking whether HELE is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold HELE indirectly through an index or sector ETF before adding more.
For the full picture, see the HELE stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about HELE against your real portfolio and see your actual exposure before deciding.
The bottom line on HELE
The bottom line: Helen of Troy Limited's story right now is Leadership Brand portfolio, with revenue (ttm) at ~$1.80 billion. If you believe that narrative continues, the call is about sizing HELE sensibly and checking overlap with what you own; if you doubt it (the risk: revenue has been declining, and a rebound is not guaranteed given consumer discretionary softness and competitive private-label pressure.), it is not for you. Decide from the thesis, not the ticker. Walnut is not an investment adviser.
Build a basket around HELE with Walnut
Use Helen of Troy Limited as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
Is HELE a good stock to buy right now?
+
The case for Helen of Troy Limited right now is Leadership Brand portfolio, with revenue (ttm) at ~$1.80 billion. If you believe that thesis holds, HELE is a way to own it and the real questions are sizing and overlap, not timing; the main risk to that view is revenue has been declining, and a rebound is not guaranteed given consumer discretionary softness and competitive private-label pressure. So it comes down to whether you believe the thesis. Walnut is not an investment adviser and this is not a recommendation.
What does Helen of Troy Limited do?
+
Helen of Troy Limited designs, markets and distributes consumer products across two segments: Home & Outdoor (OXO kitchen and storage tools, Hydro Flask hydration bottles, Osprey p
What are the main risks of HELE?
+
Revenue has been declining, and a rebound is not guaranteed given consumer discretionary softness and competitive private-label pressure. The company carries meaningful debt (~$716 million as of June 2026), so a downturn in cash flow would raise refinancing and covenant risk. Tariffs and imported-goods costs weigh on margins, and the large recent goodwill writedown signals that past acquisitions were carried above their current worth. HELE pays no dividend, and the low market capitalization relative to sales reflects genuine uncertainty rather than a guaranteed value opportunity.
What does Helen of Troy do?
+
It designs, markets and distributes consumer products across two segments, Home & Outdoor and Beauty & Wellness, under brands including OXO, Hydro Flask, Osprey, Vicks, Braun, Honeywell, PUR, Hot Tools and Drybar. It sells through retail, specialty and online channels.
Why is Helen of Troy stock so cheap relative to its sales?
+
As of June 2026 the market cap (~$641 million) is roughly a third of trailing revenue (~$1.80 billion). The low multiple reflects declining sales, tariff pressure on margins, meaningful debt (~$716 million) and a large recent goodwill writedown, not a settled bargain.
Did Helen of Troy report a big loss?
+
It reported a large GAAP net loss (~$899 million as of June 2026), but the bulk came from a non-cash goodwill and intangibles writedown of roughly $886 million. Adjusted earnings and free cash flow stayed positive over the same period.
Does Helen of Troy pay a dividend?
+
No. Helen of Troy does not currently pay a regular dividend and has been directing free cash flow toward reducing debt rather than shareholder payouts (as of June 2026).
Walnut is informational and is not an investment adviser. This page is educational and not a recommendation to buy or sell HELE; figures are approximate and dated, and your own situation, time horizon, and risk tolerance should drive any decision. Verify current data before investing.